International clinical research and the problem of benefiting from injustice
2016 (English)In: Bodily exchanges, bioethics and border crossing: perspectives on giving, selling and sharing bodies / [ed] Erik Malmqvist & Kristin Zeiler, Abingdon: Routledge, 2016, 169-184 p.Chapter in book (Refereed)
Clinical trials are increasingly “offshored” to developing countries. Many participants in these trials can plausibly be regarded as victims of deep structural injustices, e.g. severe avoidable poverty and lack of access to healthcare. This chapter discusses whether patients who benefit from drugs developed among the global poor have any special responsibility to remedy their unjust circumstances. More precisely, it examines whether such a responsibility can be grounded in the fact that these patients are beneficiaries of injustice. Finding no justification for singling out this group, the author ends by exploring the idea that the responsibility to remedy structural injustice is a more widely shared one.
Place, publisher, year, edition, pages
Abingdon: Routledge, 2016. 169-184 p.
, Routledge Studies in the Sociology of Health and Illness
Social and Clinical Pharmacy
IdentifiersURN: urn:nbn:se:liu:diva-123629ISBN: 9781138858763OAI: oai:DiVA.org:liu-123629DiVA: diva2:890315